IP Library Granted Patent US 10,492,950
Granted Patent B2
US 10,492,950 · App. 15/821,130 · Granted Dec 3, 2019

Shunt device and method for treating ocular disorders

Inventors: Mary G. Lynch (Atlanta, GA); Reay H. Brown (Atlanta, GA)
Assignee: GLAUKOS CORPORATION
A61F9/00781A61M25/007A61F9/0017A61F2230/0008A61F2250/0067A61M25/0074A61M2210/0612
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,492,950
App. No.
15/821,130
Granted
Dec 3, 2019
Kind
B2
Abstract

Shunt devices and a method for continuously decompressing elevated intraocular pressure in eyes affected by glaucoma by diverting excess aqueous humor from the anterior chamber of the eye into Schlemm's canal where post-operative patency can be maintained with an indwelling shunt device which surgically connects the canal with the anterior chamber. The shunt devices provide uni- or bi-directional flow of aqueous humor into Schlemm's canal.

Claims (22)

1. An implant designed to relieve elevated intraocular pressure, the implant comprising:

a biocompatible metal stent designed to partially reside within Schlemm's canal of an eye,

the stent having a pre-formed curved shape,

wherein the stent further includes an inlet at its proximal end shaped to reside at least partially within an anterior chamber of the eye,

wherein the stent has a distal end that is non-tubular, and

wherein the stent includes multiple fenestrations located between the proximal end and the distal end of the stent.

2. The implant of claim 1 , wherein a length of the stent comprises a trough-like aspect.

3. The implant of claim 2 , wherein the trough-like aspect extends to a distal end of the stent.

4. The implant of claim 1 , wherein a length of the stent is substantially open such that it is not fully enclosed.

5. The implant of claim 1 , wherein the fenestrations are oval-shaped.

6. The implant of claim 1 , wherein the stent is non-luminal.

7. An implant designed to relieve elevated intraocular pressure, the implant comprising:

a proximal inlet shaped to permit fluid ingress from the anterior chamber;

a curved distal portion shaped to reside within Schlemm's canal, and

a distal end that is non-tubular,

wherein the curved distal portion shaped to reside within Schlemm's canal includes multiple fenestrations along its length.

8. The implant of claim 7 , wherein the implant comprises a biocompatible metal.

9. The implant of claim 7 , wherein the distal portion comprises a trough-like shape.

10. The implant of claim 7 , wherein the implant is non-luminal.

11. The implant of claim 7 , wherein the fenestrations are oval-shaped.

12. The implant of claim 7 , wherein an inner cross-sectional dimension of the implant is between 0.1 mm and 0.5 mm.

13. The implant of claim 7 , wherein the distal portion has a length of approximately 6 mm.

Continuity (9)
Continuation 15349885 · Nov 11, 2016
Continuation 14316605 · Jun 26, 2014
Continuation 12966889 · Dec 13, 2010
Division 10987114 · Nov 12, 2004
Continuation 10445740 · May 27, 2003
Continuation 10242385 · Sep 12, 2002
Continuation 09558505 · Apr 26, 2000
Provisional Application 60131030 · Apr 26, 1999
Related Publication 20180104102A1 · Apr 19, 2018
Cited By (19)
US 1,137,672 US 12,186,237 US 12,201,555 US 12,201,557 US 12,208,034 US 12,226,308 US 12,279,822 US 12,343,288 US 12,376,989 US 12,414,798 US 12,419,783 US 12,427,057 US 12,478,503 US 12,478,504 US 12,514,750 US 12,575,972 US 12,599,497 US 12,667,486 US 12,702,294